Background: Hirsutism has a negative impact on women's quality of life. The relation between quality of life, anxiety, depression and the level of hairiness has not been described. Aims: To investigate the correlations between the levels of hairiness, quality of life, anxiety and depression. Methods: 200 patients from Malmö, Örebro and Uppsala, who had been in contact with the clinics for problems with excessive hair growth, were invited to answer a self-administered questionnaire including sociodemographic questions, EQ-5D index score, Dermatology Life Quality Index (DLQI), Hospital Anxiety and Depression Scale (HADS) and Ferriman-Gallwey scale (F-G); of these, 127 women participated in the study. Results: The mean values were: EQ-5D index 0.73 (SD = 0.27), EQ visual analogue scale 61.0 (SD = 22.6), HADS-anxiety 9.5 ± 5.3 and HADS-depression 6.5 ± 4.6. The mean DLQI was 11.8 ± 8.4, indicating a very large effect on patients' lives. All were significantly correlated with the amount of hairiness. Conclusions: Higher levels of hair growth were significantly correlated with a lower level of quality of life and symptoms of both anxiety and depression.

Keywords:
Hirsutism, Ferriman-Gallwey scale, Poor health-related quality of life, Dermatology Life Quality Index, EQ-5D index score, Hospital Anxiety and Depression Scale, Low health status
1.
Barth JH, Catalan J, Cherry CA, Day A: Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 1993;37:615-619.
2.
Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M: Quality of life of hirsute women. Postgrad Med J 1993;69:186-189.
3.
Hunter MH, Carek PJ: Evaluation and treatment of women with hirsutism. Am Fam Physician 2003;67:2565-2572.
4.
Azziz R: The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995-1007.
5.
Rosenfield RL: Clinical practice. Hirsutism. N Engl J Med 2005;353:2578-2588.
6.
Hines G, Moran C, Huerta R, Folgman K, Azziz R: Facial and abdominal hair growth in hirsutism: a computerized evaluation. J Am Acad Dermatol 2001;45:846-850.
7.
Lipton MG, Sherr L, Elford J, Rustin MHA, Clayton WJ: Women living with facial hair: the psychological and behavioral burden. J Psychosom Res 2006;61:161-168.
8.
Ekbäck M, Wijma K, Benzein E: ‘It is always on my mind': women's experiences of their bodies when living with hirsutism. Health Care Women Int 2009;30:358-372.
9.
Kitzinger C, Willmott J: ‘The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002;54:349-361.
10.
Basow SA, Braman AC: Women and body hair: social perceptions and attitudes. Psychol Women Q 1998;22:637-645.
11.
Tiggemann M, Kenyon SJ: The hairlessness norm: the removal of body hair in women. Sex Roles 1998;39:873-885.
12.
Drosdzol A, Skrzypulec V, Plinta R: Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 2010;31:168-175.
13.
Keegan A, Liao LM, Boyle M: ‘Hirsutism': a psychological analysis. J Health Psychol 2003;8:327-345.
14.
Loo WJ, Lanigan SW: Laser treatment improves quality of life of hirsute females. Clin Exp Dermatol 2002;27:439-441.
15.
Burstrom K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001;10:621-635.
16.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343.
17.
Moberg C, Alderling M, Meding B: Hand eczema and quality of life: a population-based study. Br J Dermatol 2009;161:397-403.
18.
Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
19.
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.
20.
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY: Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-664.
21.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
22.
Wetzler S, Katz MM: Problems with the differentiation of anxiety and depression. J Psychiatr Res 1989;23:1-12.
23.
Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
24.
Telles-Correia D, Barbosa A: Anxiety and depression in medicine: models and measurement (in Portuguese). Acta Med Port 2009;22:89-98.
25.
Julian LJ: Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63(suppl 11):S467-S472.
26.
Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
27.
Hatch R, Rosenfield RL, Kim MH, Tredway D: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-830.
28.
Falsetti L, Gambera A, Tisi G: Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome. Hum Reprod 2001;16:36-42.
29.
Conroy FJ, Venus M, Monk B: A qualitative study to assess the effectiveness of laser epilation using a quality-of-life scoring system. Clin Exp Dermatol 2006;31:753-756.
30.
Jayaprakasam A, Darvay A, Osborne G, McGibbon D: Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol 2002;27:306-308.
31.
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M: Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000;80:430-434.
32.
Berg M, Lindberg M: Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol 2011;25:969-972.
33.
Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-741.
34.
Rabinowitz S, Cohen R, Le Roith D: Anxiety and hirsutism. Psychol Rep 1983;53:827-830.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.